Literature DB >> 6152652

Endometrial carcinoma of the intestinal type. A first case report.

G Berger, F Fetissof, D Vitrey, J A Chayvialle, J Féroldi.   

Abstract

A primary endometrial adenocarcinoma is reported that showed abundant foci suggestive of pathologically differentiated intestinal epithelium. The tumor epithelium was composed of four main cell types. Columnar cells resembled absorptive intestinal cells and displayed glycocalyceal carcinoembryonic antigen immunostaining; mucin-producing cells and a few Paneth-like lysozyme-rich cells were irregularly distributed; a massive quantity of argyrophil cells including a few amphicrine (muco-argyrophil) ones, were detected by Grimelius-Alcian blue method. Immunocytochemical evidence was obtained for the storage of serotonin, somatostatin and gastrin/cholecystokinin in some of the endocrine cells. These findings suggest that the tumor arose from a pluripotential stem cell of the glandular epithelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152652

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  3 in total

1.  Proceedings of the 2021 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Shambhunath Choudhary; Gregory A Krane; Quinci Plumlee; Erin M Quist; Andrew W Suttie; Debra A Tokarz; Jerrold M Ward; Michelle Cora
Journal:  Toxicol Pathol       Date:  2021-10-11       Impact factor: 1.902

2.  Intestinal differentiated mucinous adenocarcinoma of the endometrium with sporadic MSI high status: a case report.

Authors:  Mafalda Trippel; Sara Imboden; Andrea Papadia; Michael D Mueller; Nando Mertineit; Kirsi Härmä; Alina Nicolae; Erik Vassella; Tilman T Rau
Journal:  Diagn Pathol       Date:  2017-05-12       Impact factor: 2.644

3.  Intestinal type adenocarcinoma of the endometrium with signet ring cells, a rare aggressive variant.

Authors:  Kieran Seay; Bethany Bustamante; Alexander Truskinovsky; Andrew Menzin; Gary L Goldberg
Journal:  Gynecol Oncol Rep       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.